Interhemispheric Connectivity and Compensation

October 7, 2025 updated by: Washington University School of Medicine

Interhemispheric Communication and Compensation in Peripheral Nerve Injury

The goal of this study is to determine which parts of the brain make it possible for some people to move skillfully with their left non-dominant hand.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This is a one-visit study, in which right-handed participants (individuals with unilateral peripheral nerve injury to the right upper limb, and healthy controls) will complete surveys and perform movement tasks. Movement tasks will be performed inside and outside a magnetic resonance imaging (MRI) scanner.

Some participants will also receive transcranial magnetic stimulation (TMS) to briefly interfere with these putative brain networks.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • St Louis, Missouri, United States, 63108
        • Washington University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

This study contains two groups: typical controls and patients. Participants will be matched by age and sex between the two groups. No randomization will occur.

A. Inclusion criteria (all participants):

  1. Age ≥ 18
  2. English speaking and reading
  3. Able to fit in Prisma scanner bore (60 cm diameter)
  4. Right hand dominant (self report, and Edinburgh handedness ≥ +40)

B. Inclusion criteria (patients only):

  1. Chronic unilateral upper extremity peripheral nerve injury to the right side

    • "Chronic" defined as ≥ 6 months since injury
    • "Upper extremity" defined as hand, arm, or shoulder (including e.g. brachial plexus)
    • "Injury" defined as localized cause (e.g. mechanical/tumor, not distributed pathology), including compression
  2. Some impairment to writing, requiring both of:

    • Difficulty writing, as determined by score 2+ (Mild+) on "How much difficulty have you had in the last week with writing?" (From Disabilities of the Arm, Shoulder, and Hand survey question #2)
    • Box and Blocks motor performance ≥1 standard deviation below the mean of age-matched healthy adults (Mathiowetz et al. 1985, AJOT).

C. Exclusion criteria (all participants)

  1. Currently intoxicated or otherwise non-compliant
  2. Chronic pain diagnosis unrelated to the nerve injury
  3. Uncorrected visual impairment that interferes with ability to see drawings in MRI
  4. Motor function diagnoses that affect function of the left hand, now or in past 2 years
  5. Motor function diagnoses currently affecting the right hand, unrelated to the nerve injury

    • This is not meant to exclude a single event with complex consequences (e.g. nerve and tendon)
    • This is not meant to exclude multiple nerve injuries in the same arm, if each one is eligible (II.B.1)
    • This is meant to exclude e.g. injury and unrelated musculoskeletal disorder in same arm
  6. Upper extremity surgery, including peripheral nerve surgery, within last 2 months
  7. Contraindication for MRI
  8. Contraindication for transcranial magnetic stimulation (TMS)

    • May exclude from TMS only (since not all participants undergo TMS), or exclude from full study
  9. Amputation affecting any part of thumb, index, or middle fingers (including higher level, e.g. whole hand)
  10. History of chronic cocaine use (based on medical record or volunteered; will not actively inquire)
  11. Diagnosis of schizophrenia or other rare psychiatric disorder

    • This is not meant to exclude depression or anxiety
  12. History of major neurological diagnosis, e.g. stroke, traumatic brain injury, Alzheimer's, Parkinson's

    • This is not meant to exclude concussion UNLESS < 6 months ago, or post-concussion syndrome (diagnosed or self-report)

D. Exclusion criteria (controls only)

1. Motor function diagnoses that affect function of either hand, now or in past 2 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Movement task

All participants perform the STEGA-MRI (standardized tracing evaluation & grapheme assessment - MRI) precision drawing task during fMRI scanning.

Motor assessments outside the MRI do not qualify as interventions.

Precision drawing task (movement assessment)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BOLD (blood oxygen level dependent) signal in ROIs (regions of interest)
Time Frame: Day 1
BOLD signal in key ROIs (primary motor and posterior parietal cortex). ROI selection may be revisited after preliminary data review (35 participants)
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Drawing smoothness
Time Frame: Day 1
Velocity smoothness in STEGA-MRI (Standardized Tracing Evaluation and Grapheme Assessment - MRI version) task
Day 1
Hand choice
Time Frame: Day 1
Percentage of grasps made with right hand
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Benjamin A Philip, PhD, Washington University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 9, 2021

Primary Completion (Actual)

August 1, 2025

Study Completion (Actual)

August 1, 2025

Study Registration Dates

First Submitted

December 25, 2021

First Submitted That Met QC Criteria

January 11, 2022

First Posted (Actual)

January 26, 2022

Study Record Updates

Last Update Posted (Estimated)

October 9, 2025

Last Update Submitted That Met QC Criteria

October 7, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

For participants who consent to us sharing their data with other researchers, we will share all anonymized data (behavioral, survey, and MRI), including data dictionaries.

Note that this clinical trial is a "prospective basic science study involving human participants;" i.e., a study that falls within the NIH definition of clinical trial while also meeting the definition of basic research.

IPD Sharing Time Frame

Will become available after summary data are published. Will remain available indefinitely.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on STEGA-MRI

Subscribe